Xcout IntelSign inSubscribe

BIOREGENX, INC. competitors & alternatives

BRGXMedical - Diagnostics & ResearchChattanooga, United States

The 12 closest competitors and alternatives to BIOREGENX, INC. among medical - diagnostics & research companies — ranked by similarity to what BIOREGENX, INC. actually does, not by market-cap band.

$7.3MMarket cap
6Employees
12Competitors listed

Subscribe to see BIOREGENX, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About BIOREGENX, INC.

BioRegenx, Inc. develops, manufactures, and sells medical test equipment and science-based nutritional products in the United States and internationally. The company offers Endocalyx Pro, a dietary supplement targeting microvascular capillary health and a range of other supplements under the MyBodyRx brand name; GlycoCheck software; and other health and wellness devices, such as pulsed electro-magnetic field devices, as well as StimaWELL and ReLounge, an electronic muscle stimulation therapy device; and markets hydrogen water products. It also develops TruScan.Ai mobile app/website that integrates additional health indicators; and VitalWellness app, which merge its DNA and epigenetics platform. In addition, the company operates a social media content management platform, including its interactive search engine. Further, it provides DocSun Artificial Intelligence (AI) Engine, which integrates advanced ballistocardiography that detects an individual's heartbeat without touch; photoplethysmography, a method that uses light to track the flow of blood; and distributes wellness devices. The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.

BIOREGENX, INC. at a glance

BIOREGENX, INC. is a medical - diagnostics & research company headquartered in Chattanooga, United States. It is publicly listed (BRGX) with a market capitalisation of $7.3M. Xcout tracks 12 named people at BIOREGENX, INC., including William Resides (CEO, Interim CFO, Chairman, & Executive Director).

BIOREGENX, INC. leadership

  • William ResidesCEO, Interim CFO, Chairman, & Executive Director
  • Diane BouisActing Chief Executive Officer MVHS
  • Gary HennerbergSecretary
  • Gary HennerbergDirector
  • Gary KissDirector
  • Jody Marie WalkerDirector

6 more named people on record for BIOREGENX, INC., with roles, board committees and tenure — see the full roster →

Top 12 BIOREGENX, INC. competitors

Ranked by semantic similarity — how close each company is to BIOREGENX, INC. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

CELLBXHEALTH PLCCLBX · BiotechGuildford, United Kingdom
63% matchPublic

Biotech

CelLBxHealth plc is a medical diagnostics firm specializing in the creation of cancer detection solutions, with operations spanning the United Kingdom, broader Europe, North America, and other global markets. A flagship offering is the Parsortix PC1 system, a medical device engineered to isolate and collect whole circulating tumor cells (CTCs) from the blood of patients with metastatic breast cancer, preparing them for further user-validated analysis. The company also provides the Parsortix PR1 system for general CTC capture and collection from blood samples. Beyond its core systems, CelLBxHealth offers the Portrait+ CTC Staining kit, a laboratory solution designed for the precise identification, characterization, and quantification of both epithelial and mesenchymal circulating tumor cells, boasting strong analytical sensitivity and specificity. Another key product is the CellKeep Slide, which facilitates CTC harvesting. The company extends its expertise through various laboratory services, including advanced CTC enrichment and liquid biopsy analysis. Its assay portfolio comprises Portrait Flex, an immunofluorescence assay for detecting epithelial, mesenchymal, and epithelial-to-mesenchymal transition states, as well as assessing DNA damage response. Additionally, CelLBxHealth provides Portrait PD-L1 for CTC evaluation and develops customized CTC assays. Strategic collaborations underpin some of its development efforts; it has partnered with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. involves utilizing a pan-cancer next-generation sequencing (NGS) panel. Originally established in 1994 as ANGLE plc, the company rebranded to CelLBxHealth plc in October 2025 and operates from its base in Guildford, UK.

Market cap$20.4M
Employees119
CELLBXHEALTH PLC competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of BIOREGENX, INC. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for BIOREGENX, INC.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →